Nrx Pharmaceuticals Inc (NRXP) Stock Price, Quote & News

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100,...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 254 6134

Website: www.nrxpharma.com

Address:

1201 N. Market Street, Suite 111, Wilmington, United States

alwaysWinVlmr Jun. 10 at 10:33 PM

$NRXP @jonny80s @SoloBueno I didn't accuse @SoloBueno of defamation. He accused me of that, and threatened to go to court with it. Two idiots.

2 · Reply

nick_m Jun. 10 at 8:49 PM

$NRXP patience is the key

0 · Reply

fuctonfauci Jun. 10 at 5:44 PM

$NRXP Who did we have to sell ourselves to today?

0 · Reply

retired24 Jun. 10 at 5:31 PM

$NRXP Just waiting things out

2 · Reply

alwaysWinVlmr Jun. 10 at 4:37 PM

$NRXP @SoloBueno you are a pathetic weasel.

0 · Reply

Mreckted Jun. 10 at 3:20 PM

$NRXP it's not a serious person, I wouldn't hold my breath on having any sort of real dialogue. They seem more interested in larping as a knowledgeable investor. I must have hit a nerve, because they have actually blocked me, whereas they seem more than happy to go back and forth endlessly with others. They are just attention seeking and likely misrepresenting who they are. More than likely a retail investor who lost their ass and is salty about it.

2 · Reply

STACKD0E Jun. 10 at 1:55 PM

$NRXP 🙃✨️

0 · Reply

jacksparo Jun. 10 at 1:52 PM

$CADL $IBRX $MNKD $LAES $NRXP You what I care about ? The results and the real success! If someone will come and say Oh Jack is a spamming or whatever nonsense jealousy talk will be blocked and banned for a lifetime. I have been trading long enough to know what I am talking about you do not want to see my posts and you are bothered block me please and thank you! let us see what will happen in this market today!

0 · Reply

jonny80s Jun. 10 at 1:15 PM

$NRXP how’s the now 10 day late FDA response to clinical data submission coming along? Those module 5, clinical study reports, are pretty important. @JavittMD are we about to pivot to schizophrenia? 14 business days left of Q2 and there are a whole lot of loose ends that require tying. Looking forward to be proven wrong concerning management’s character.

0 · Reply

alwaysWinVlmr Jun. 10 at 1:03 PM

$NRXP @SoloBueno have you ever lied or manipulated on Stocktwits? You declined to answer this question for 2 days. Maybe you'll answer now?

1 · Reply

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

Jun 4, 2026, 5:12 PM EDT - 6 days ago

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters' Option

2026-06-03T15:17:33.000Z - 7 days ago

NRx Pharmaceuticals 5.7M share Spot Secondary priced at $3.50

Jun 3, 2026, 8:18 AM EDT - 7 days ago

NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

2026-06-02T20:05:59.000Z - 8 days ago

NRx Pharmaceuticals announces common stock offering, no amount given

Jun 2, 2026, 4:01 PM EDT - 8 days ago

NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

May 28, 2026, 7:00 AM EDT - 13 days ago

NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026

May 27, 2026, 7:00 AM EDT - 14 days ago

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

May 18, 2026, 8:00 AM EDT - 23 days ago

NRx Pharmaceuticals Earnings Call Transcript: Q1 2026

May 18, 2026, 8:00 AM EDT - 23 days ago

NRx Pharmaceuticals Quarterly report: Q1 2026

May 18, 2026, 8:00 AM EDT - 23 days ago

NRx Pharmaceuticals Earnings release: Q1 2026

May 18, 2026, 7:00 AM EDT - 23 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 14, 2026, 7:00 AM EDT - 27 days ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update

2026-05-13T10:11:36.000Z - 4 weeks ago

NRx Pharmaceuticals initiated with a Buy at Lucid Capital

2026-05-07T18:39:21.000Z - 4 weeks ago

NRx Pharmaceuticals gets FDA clearance to initiate NRX-101 trial

May 7, 2026, 8:00 AM EDT - 4 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

2026-05-05T13:49:41.000Z - 5 weeks ago

NRx Pharmaceuticals receives first commercial manufacturing order for ketamine

May 5, 2026, 7:00 AM EDT - 5 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine

2026-04-22T11:48:51.000Z - 7 weeks ago

NRx Pharmaceuticals gets FDA feedback on ketamine program

Apr 22, 2026, 7:00 AM EDT - 7 weeks ago

NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program

2026-04-20T14:07:54.000Z - 7 weeks ago

White House shift on psychedelics positive for NRx, says D. Boral

2026-04-20T11:20:02.000Z - 7 weeks ago

NRx Pharmaceuticals welcomes the newly-signed Executive Order

Apr 20, 2026, 7:00 AM EDT - 7 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

2026-04-16T15:26:34.000Z - 7 weeks ago

NRx Pharmaceuticals announces incorporation of NRx Defense Systems

Apr 15, 2026, 7:00 AM EDT - 2 months ago

NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications

2026-04-13T11:11:54.000Z - 2 months ago

NRx Pharmaceuticals appoints Glenn Tyson chief commercial officer

Apr 13, 2026, 7:00 AM EDT - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

2026-04-06T11:18:26.000Z - 2 months ago

NRx Pharmaceuticals announces FDA labeling alignment for ketamine product

Apr 6, 2026, 7:00 AM EDT - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application

Mar 30, 2026, 7:00 AM EDT - 2 months ago

Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network

Mar 24, 2026, 8:00 AM EDT - 2 months ago

NRx Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 24, 2026, 8:00 AM EDT - 2 months ago

NRx Pharmaceuticals Earnings release: Q4 2025

Mar 24, 2026, 8:00 AM EDT - 2 months ago

NRx Pharmaceuticals Annual report: Q4 2025

Mar 24, 2026, 7:00 AM EDT - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

Mar 23, 2026, 10:00 AM EDT - 2 months ago

NRx Pharmaceuticals Transcript: AGM 2026

Mar 19, 2026, 7:00 AM EDT - 2 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

Mar 17, 2026, 7:00 AM EDT - 3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx's Preservative-Free Ketamine Application

Mar 16, 2026, 7:00 AM EDT - 3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Mar 9, 2026, 7:00 AM EDT - 3 months ago

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

Mar 2, 2026, 7:00 AM EST - 3 months ago

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Feb 24, 2026, 7:00 AM EST - 3 months ago

NRx Pharmaceuticals Proxy statement: Proxy Filing

Feb 23, 2026, 7:00 AM EST - 3 months ago

NRx Pharmaceuticals Proxy statement: Proxy Filing

Feb 17, 2026, 7:00 AM EST - 4 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Feb 13, 2026, 7:00 AM EST - 4 months ago

NRx Pharmaceuticals Proxy statement: Proxy Filing

Jan 16, 2026, 7:03 AM EST - 5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

Jan 14, 2026, 7:03 AM EST - 5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Jan 5, 2026, 6:57 AM EST - 5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

Dec 18, 2025, 7:05 AM EST - 6 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

Dec 12, 2025, 7:00 AM EST - 6 months ago

NRx Pharmaceuticals Registration statement: Registration Filing

Dec 3, 2025, 7:00 AM EST - 6 months ago

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

Dec 2, 2025, 9:00 AM EST - 6 months ago

NRx Pharmaceuticals Transcript: Study Update

Dec 2, 2025, 9:00 AM EST - 6 months ago

NRx Pharmaceuticals Press release: Study Update

Dec 2, 2025, 8:30 AM EST - 6 months ago

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

Dec 2, 2025, 7:30 AM EST - 6 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

Dec 1, 2025, 8:03 AM EST - 6 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

Nov 17, 2025, 8:30 AM EST - 7 months ago

NRx Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 17, 2025, 8:30 AM EST - 7 months ago

NRx Pharmaceuticals Earnings release: Q3 2025

Nov 17, 2025, 8:30 AM EST - 7 months ago

NRx Pharmaceuticals Quarterly report: Q3 2025

Nov 17, 2025, 8:03 AM EST - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 12, 2025, 8:31 AM EST - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

Nov 10, 2025, 8:03 AM EST - 7 months ago

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

Oct 20, 2025, 8:03 AM EDT - 8 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Oct 8, 2025, 9:30 AM EDT - 8 months ago

NRx Pharmaceuticals Transcript: Noble Capital Markets Emerging Growth Virtual Investor Conference

Oct 6, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

Sep 29, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

Sep 24, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

Sep 8, 2025, 4:30 PM EDT - 9 months ago

NRx Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 8:17 AM EDT - 9 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Sep 3, 2025, 8:03 AM EDT - 10 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

Sep 2, 2025, 1:19 PM EDT - 10 months ago

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

Sep 2, 2025, 8:41 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

Aug 27, 2025, 8:03 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

Aug 20, 2025, 8:00 AM EDT - 10 months ago

NRx Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 20, 2025, 8:00 AM EDT - 10 months ago

NRx Pharmaceuticals Earnings release: Q2 2025

Aug 20, 2025, 8:00 AM EDT - 10 months ago

NRx Pharmaceuticals Quarterly report: Q2 2025

Aug 18, 2025, 8:10 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 13, 2025, 6:06 PM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Aug 11, 2025, 4:05 PM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

Aug 11, 2025, 8:03 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

Aug 8, 2025, 8:03 AM EDT - 10 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

Aug 4, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

Jul 29, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

alwaysWinVlmr Jun. 10 at 10:33 PM

$NRXP @jonny80s @SoloBueno I didn't accuse @SoloBueno of defamation. He accused me of that, and threatened to go to court with it. Two idiots.

2 · Reply

nick_m Jun. 10 at 8:49 PM

$NRXP patience is the key

0 · Reply

fuctonfauci Jun. 10 at 5:44 PM

$NRXP Who did we have to sell ourselves to today?

0 · Reply

retired24 Jun. 10 at 5:31 PM

$NRXP Just waiting things out

2 · Reply

alwaysWinVlmr Jun. 10 at 4:37 PM

$NRXP @SoloBueno you are a pathetic weasel.

0 · Reply

Mreckted Jun. 10 at 3:20 PM

2 · Reply

STACKD0E Jun. 10 at 1:55 PM

$NRXP 🙃✨️

0 · Reply

jacksparo Jun. 10 at 1:52 PM

0 · Reply

jonny80s Jun. 10 at 1:15 PM

0 · Reply

alwaysWinVlmr Jun. 10 at 1:03 PM

$NRXP @SoloBueno have you ever lied or manipulated on Stocktwits? You declined to answer this question for 2 days. Maybe you'll answer now?

1 · Reply

tootlicket Jun. 10 at 1:01 PM

$NRXP You have mentioned Hal more than any person on this board. Obsessed are we? Its like any other bio with no revenue. Might as well go to Vegas. You act like someone owes you something. I have seen warnings to investment in every filing. This stock should have only been traded since Covid. Dont feel so let down. Just learn how to invest.

2 · Reply

SoloBueno Jun. 10 at 12:33 PM

$NRXP This has been a story stock since SPAC . Along the way there have been some great stories and story tellers…. The narrative pivoted from COVID to chronic pain to dividends to spinoffs to UTI to clinics. Board members resigned. CEOs departed. Capital was raised. Reverse splits executed. When execution lags, blame shifts to “Hal Mintz” and his alleged burner accounts. That’s pattern, and facts. Short-term trades exist in any volatility. Long-term investors betting on asymmetrical risk based on the story (s) press releases and regulatory filings have faced dilution, not data. Past performance does not indicate future results. Do management’s stripes change? The record shows repeated narrative shifts and capital raises without sustained value creation- in reality -catastrophic catalyst failures. It looks as though Alvogen alone was left with a 4 million hole in their balance sheet. Investors should review SEC filings and do their own diligence. Is 100 mil run rate another story?

1 · Reply

the_franz Jun. 10 at 7:16 AM

$NRXP Sorry, @djcal. Forget my question. I haven't seen your posts with your DD when replying. I didn't know you did it by simply querying a LLM. All the best and good luck. You will need it.

1 · Reply

Live_a_little Jun. 10 at 5:53 AM

$NRXP I’ve been here since 2022, what’s another few months. Avg currently in the 3s with the average down method. Too close to not wait it out.

0 · Reply

systemish Jun. 10 at 1:55 AM

$NRXP Do not be surprised of a massive sell the news if approval does happen. This has historically been an Armistice strategy. Using their warrants as synthetic cover. Fully diluted with these warrants and others NRXP is close to 50M but honestly I have lost track.

1 · Reply

systemish Jun. 10 at 1:46 AM

$NRXP As this gets closer to July 29th look for options market manipulation on July 17 close. Unlikely to close above $5 until post that date. Also warrant arbitrage hedging from holders such as Armistice who still hold possibly 2.6M redeemable warrants at $2.05. Now that B group has taken a large stake it should free up Armistice to liquidate quickly as they aren’t bound to the 9.99% beneficial ownership block.

1 · Reply

djcal Jun. 10 at 1:44 AM

$NRXP Where the money from the June equity offering is going and how you will benefit from it - Page 2

0 · Reply

djcal Jun. 10 at 1:42 AM

$NRXP Where the money from the June equity offering is going and how you will benefit from it - Page 1

0 · Reply

djcal Jun. 10 at 12:17 AM

$NRXP That is all I am posting for tonight.

0 · Reply

djcal Jun. 10 at 12:16 AM

$NRXP Who are possible buyers for NXRP and KETAFREE and why. - Page 3

0 · Reply

djcal Jun. 10 at 12:14 AM

$NRXP Who are possible buyers for NXRP and KETAFREE and why. - Page 2

0 · Reply

djcal Jun. 10 at 12:13 AM

$NRXP Who are possible buyers for NXRP and KETAFREE and why. - Page 1

0 · Reply

Market Cap	156.87M
Revenue (ttm)	1.23M
Net Income (ttm)	-28.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,326.83%
Debt to Equity Ratio	0.00

Volume	599,800
Avg Vol	1,346,542
Day's Range	N/A - N/A
Shares Out	36.23M
Stochastic %K	26%
Beta	2.14
Analysts	Strong Sell
Price Target	$39.67